NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-031-2026-0-JP-03 Antigenic Epstein Barr Virus Polypeptides JP DIV 2025-123756 Pending
NIAID E-137-2018-2-AU-01 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response AU DIV 2025208502 Pending
NCATS E-112-2023-0-IL-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF IL National Stage 322325 Pending
NINDS E-047-2023-1-EP-01 Genetic control of MRI signal EP National Stage 24742070.6 Pending
NINDS E-070-2024-0-CA-01 Methods of Diagnosing and Treating Multiple Sclerosis CA National Stage 3280851 Pending
NCI E-075-2024-0-PC-01 OXYNITIDINE DERIVATIVES USEFUL AS TYROSYL-DNA PHOSPHODIESTERASE INHIBITORS AND RADIOSENSITIZERS PCT PCT PCT/US2025/038739 Pending
NCI E-199-2022-0-CN-01 HUMAN PAPILLOMAVIRUS, VARICELLA-ZOSTER VIRUS, AND RABIES VIRUS ANTIGENS AND USES THEREOF IN CANCER IMMUNOTHERAPY CN National Stage 202480008609.5 Pending
NCI E-161-2024-0-PC-01 T CELL RECEPTORS AGAINST RAS WITH G12D, G12V, G13D OR Q61R MUTATION PCT PCT PCT/US2025/038428 Pending
NIAID E-102-2018-0-US-02 ANTIBODY-MEDIATED CONDITIONING WITH IMMUNOSUPPRESSION TO ENABLE ALLOGENEICTRANSPLANTATION US CON 19/273,430 Pending
NIAID E-024-2023-0-EP-01 MONOCLONAL ANTIBODIES FOR TREATING SARS-COV-2 INFECTION EP National Stage 23844049.9 Pending
NCI E-175-2016-0-US-03 ANTI-KRAS-G12D T CELL RECEPTORS US CON 19/269,450 Pending
NIAID E-067-2024-0-PC-01 COMPOSITIONS AND METHODS FOR DETECTING LYMPHATIC FILARIASIS PCT PCT PCT/US2025/037585 Pending
NEI E-203-2023-0-CA-01 APPARATUS AND METHOD FOR EXTRACELLULAR IMPEDANCE SPECTROSCOPY OF EPITHELIA CA National Stage 3279965 Pending
NCI E-162-2024-0-PC-01 Reverse Thiazine Kinase Inhibitors PCT PCT PCT/US2025/037257 Pending
NIAID E-234-2016-1-US-07 PREFUSION CORONAVIRUS SPIKE PROTEINS AND THEIR USE US CON 19/267,156 Pending
NINDS E-047-2023-1-US-01 Genetic control of MRI signal US National Stage 19/147,173 Pending
NCATS E-253-2017-0-US-04 C-ABL TYROSINE KINASE INHIBITORY COMPOUND EMBODIMENTS AND METHODS OF MAKING AND USING THE SAME US DIV 19/264,475 Pending
NIBIB E-040-2023-1-US-01 INTUBATION SYSTEM AND CHAMBER TANK US National Stage 19/146,454 Abandoned
NIDDK E-032-2023-0-US-02 COMPOUNDS AND METHOD FOR TREATING HIV INFECTION US National Stage 19/146,060 Pending
CC E-103-2018-0-US-02 METHODS AND COMPOSITIONS FOR DETECTING TRANSFUSION-TRANSMITTED PATHOGENS US DIV 19/261,599 Pending
NIAID E-030-2023-0-EP-01 STABILIZED PFS48/45 PROTEINS AND USES THEREOF EP National Stage 23848442.2 Pending
NCI E-244-2015-0-KR-10 BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE KR DIV 2025-7022506 Pending
NCI E-176-2014-0-EP-01 ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS EP DIV 25187143.0 Pending
NEI E-058-2018-0-CA-01 USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS CA DIV 3279009 Pending
NEI E-028-2023-0-EP-01 PIGMENT EPITHELIUM-DERIVED FACTOR PEPTIDES AND USE FOR TREATING RETINAL
DEGENERATION 		EP National Stage 23720018.3 Pending
NCI E-247-2015-0-US-09 IL-7R-ALPHA SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA US CON 19/256,800 Pending
NINDS E-119-2021-1-PC-01 2,4-DIPHENYL-3,4-DIHYDROQUINAZOLINE DERIVATIVES AND RELATED COMPOUNDS AS D2 DOPAMINE RECEPTOR-SELECTIVE ANTAGONISTS PCT PCT PCT/US2025/035353 Pending
NIAID E-198-2025-1-US-02 VIRAL SEROLOGY ASSAYS US CON 19/248,703 Pending
NIA E-183-2024-0-PC-01 2-(PIPERIDIN-3-YL)ISOINDOLE-1,3-DIONE ANALOGS AND USES THEREOF PCT PCT PCT/US2025/034951 Pending
NCI E-029-2019-0-CN-01 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION CN DIV 202510854434.6 Pending
NIAID E-030-2023-0-IN-01 STABILIZED PFS48/45 PROTEINS AND USES THEREOF IN National Stage 202517060138 Pending
NIBIB E-076-2025-0-US-02 VASCULARIZED THYROID-ON-A-CHIP US ORD 19/247,851 Pending
NHLBI E-255-2023-0-PC-01 AZOLE COMPOUNDS USEFUL AS INHIBITORS OF VOLTAGE-DEPENDENT ANION CHANNEL OLIGOMERIZATION PCT PCT PCT/US2025/034724 Pending
NIAID E-191-2018-0-US-02 Improved Methods Of Manufacturing Peptide-Based Vaccines US DIV 19/246,539 Pending
NINDS E-070-2024-0-SG-01 Methods of Diagnosing and Treating Multiple Sclerosis SG National Stage 11202504302S Pending
NIAID E-004-2023-1-US-01 EBOLAVIRUS (SUDAN AND ZAIRE) ANTIBODIES FROM NON-HUMAN PRIMATES AND HUMAN VACCINEES US National Stage 19/141,976 Pending
NIAID E-030-2023-0-US-02 STABILIZED PFS48/45 PROTEINS AND USES THEREOF US National Stage 19/142,034 Pending
NIAID E-174-2023-0-CN-01 Self-Assembling Nanoparticles CN National Stage 202380086935.3 Pending
NCI E-189-2020-1-TW-01 HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION TW DIV 114122865 Pending
NIAID E-137-2018-2-US-01 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response US DIV 19/242,746 Pending
NIAID E-024-2023-0-US-02 MONOCLONAL ANTIBODIES FOR TREATING SARS-COV-2 INFECTION US National Stage 19/141,012 Pending
NICHD E-037-2023-0-US-02 SINGLE SOURCE-DETECTOR SEPARATION APPROACH TO CALCULATE TISSUE OXYGEN SATURATION US National Stage 19/140,070 Pending
NEI E-208-2024-0-PCT-01 Suppression of Neurodegenerative Diseases by Single Domain Antibody PCT PCT PCT/IB2025/056102 Pending
NEI E-208-2024-0-US-02 Suppression of Neurodegenerative Diseases by Single Domain Antibody US ORD 19/237,985 Pending
NEI E-208-2024-0-TW-01 Suppression of Neurodegenerative Diseases by Single Domain Antibody TW ORD 114122027 Pending
NIDDK E-033-2023-0-EP-01 THYCLOTIDE PEPTIDE CONJUGATES WITH CELL PERMEABILITY AND INHIBITORY ACTIVITY EP National Stage 23828316.2 Pending
NIA E-249-2016-0-EP-01 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM EP DIV 25181393.7 Pending
NCI E-009-2023-0-EP-01 IMPLICATIONS OF CXCR3 EXPRESSION ON MYELOID CELLS FOR IMMUNOTHERAPY OF CANCER AND MYELOID-MEDIATED DISEASES EP National Stage 23821436.5 Pending
NIDDK E-033-2023-0-US-02 THYCLOTIDE PEPTIDE CONJUGATES WITH CELL PERMEABILITY AND INHIBITORY ACTIVITY US National Stage 19/136,698 Pending
NIAID E-150-2021-0-US-03 NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST WESTERN, EASTERN, AND VENEZUELAN EQUINE ENCEPHALITIS VIRUS (EVV) US National Stage 19/136,772 Pending